Lioe TF - Search Results

1

BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene.

Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, Mullan PB, Reid G, Johnston PG, Watson PH, Harkin DP. Kennedy RD, et al. Among authors: lioe tf. Cancer Res. 2005 Nov 15;65(22):10265-72. doi: 10.1158/0008-5472.CAN-05-1841. Cancer Res. 2005. PMID: 16288014

2

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.

Carser JE, Quinn JE, Michie CO, O'Brien EJ, McCluggage WG, Maxwell P, Lamers E, Lioe TF, Williams AR, Kennedy RD, Gourley C, Harkin DP. Carser JE, et al. Among authors: lioe tf. Gynecol Oncol. 2011 Dec;123(3):492-8. doi: 10.1016/j.ygyno.2011.08.017. Epub 2011 Sep 13. Gynecol Oncol. 2011. PMID: 21920589

3

Activation of a cGAS-STING-mediated immune response predicts response to neoadjuvant chemotherapy in early breast cancer.

Parkes EE, Savage KI, Lioe T, Boyd C, Halliday S, Walker SM, Lowry K, Knight L, Buckley NE, Grogan A, Logan GE, Clayton A, Hurwitz J, Kirk SJ, Xu J, Sidi FA, Humphries MP, Bingham V; Neo-DDIR Investigators; James JA, James CR, Paul Harkin D, Kennedy RD, McIntosh SA. Parkes EE, et al. Br J Cancer. 2022 Feb;126(2):247-258. doi: 10.1038/s41416-021-01599-0. Epub 2021 Nov 2. Br J Cancer. 2022. PMID: 34728791 Free PMC article.

4

Molecular classification of non-invasive breast lesions for personalised therapy and chemoprevention.

Buckley N, Boyle D, McArt D, Irwin G, Harkin DP, Lioe T, McQuaid S, James JA, Maxwell P, Hamilton P, Mullan PB, Salto-Tellez M. Buckley N, et al. Oncotarget. 2015 Dec 22;6(41):43244-54. doi: 10.18632/oncotarget.6525. Oncotarget. 2015. PMID: 26657114 Free PMC article.

5

The prognostic significance of the aberrant extremes of p53 immunophenotypes in breast cancer.

Boyle DP, McArt DG, Irwin G, Wilhelm-Benartzi CS, Lioe TF, Sebastian E, McQuaid S, Hamilton PW, James JA, Mullan PB, Catherwood MA, Harkin DP, Salto-Tellez M. Boyle DP, et al. Among authors: lioe tf. Histopathology. 2014 Sep;65(3):340-52. doi: 10.1111/his.12398. Epub 2014 Apr 16. Histopathology. 2014. PMID: 24612173

6

Prognostic significance of glycoprotein pMQ1 in breast cancer.

Fon LJ, Lioe TF, Mulligan KA, Johnston PG, McCormick D, Spence RA. Fon LJ, et al. Among authors: lioe tf. Br J Surg. 2006 Mar;93(3):309-14. doi: 10.1002/bjs.5231. Br J Surg. 2006. PMID: 16392102

7

Breast cancer in women under 40 years of age: a series of 57 cases from Northern Ireland.

McAree B, O'Donnell ME, Spence A, Lioe TF, McManus DT, Spence RA. McAree B, et al. Among authors: lioe tf. Breast. 2010 Apr;19(2):97-104. doi: 10.1016/j.breast.2009.12.002. Epub 2010 Jan 8. Breast. 2010. PMID: 20060718 Free article.

8

Completion mastectomy after breast conserving surgery.

O'Donnell ME, Salem A, Badger SA, Sharif MA, Lioe T, Spence RA. O'Donnell ME, et al. Breast. 2008 Apr;17(2):199-204. doi: 10.1016/j.breast.2007.10.001. Epub 2007 Nov 19. Breast. 2008. PMID: 18024117

9

The role of fine needle aspiration cytology (FNAC) in the investigation of superficial lymphadenopathy; uses and limitations of the technique.

Lioe TF, Elliott H, Allen DC, Spence RA. Lioe TF, et al. Cytopathology. 1999 Oct;10(5):291-7. doi: 10.1046/j.1365-2303.1999.00183.x. Cytopathology. 1999. PMID: 10588346 Clinical Trial.

10

Barium sulphate particles in breast mimicking malignant type microcalcification.

Bamford L, Lioe TF, O'Rourke DM, Buckley MR. Bamford L, et al. Among authors: lioe tf. Breast J. 2009 May-Jun;15(3):305-6. doi: 10.1111/j.1524-4741.2009.00724.x. Breast J. 2009. PMID: 19645790 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters